Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Transactions
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
CC transcript
Appointed director
Inv. presentation
Acq. announced
ENDO HEALTH SOLUTIONS INC. (ENDP) Create: Alert

All | News | Filings
Date FiledTypeDescription
12/17/2013 8-K/A Acquisition/merger/asset purchase announced
10/05/2012 8-K/A Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
10/13/2011 8-K/A Financial Statements and Exhibits
Docs: "The unaudited condensed consolidated financial statements of Generics International (US), Inc., including the consolidated balance sheet as of September 30, 2010, and the related consolidated statements of operations, stockholder's equity and cash flows for the nine-month periods ended September 30, 2010 and 2009 and the notes thereto, are incorporated herein by reference to of the Current Report on Form 8-K/A filed with the Commission on February 14, 2011",
"Audited consolidated financial statements of Generics International (US), Inc. and Subsidiaries as of and for the year ended December 31, 2009"
08/31/2011 8-K/A Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits
Docs: "Consent of Independent Registered Public Accounting Firm",
"Consent of Independent Registered Public Accounting Firm",
"Unaudited pro forma condensed combined financial information for the three months ended March 31, 2011 and for the year ended December 31, 2010",
"Unaudited pro forma condensed combined financial information for the three months ended March 31, 2011 and for the year ended December 31, 2010"
02/14/2011 8-K/A Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits
Docs: "The unaudited condensed consolidated financial statements of Generics International (US), Inc., including the consolidated balance sheet as of September 30, 2010, and the related consolidated statements of operations, stockholder's equity and cash flows for the nine-month periods ended September 30, 2010 and 2009 and the notes thereto, are attached as and incorporated herein by reference",
"Audited consolidated financial statements of Generics International (US), Inc. and Subsidiaries as of and for the year ended December 31, 2009",
"Unaudited consolidated financial statements of Generics International (US), Inc. and Subsidiaries as of September 30, 2010 and for the nine-month periods ended September 30, 2010 and 2009",
"Unaudited pro forma financial information for the year ended December 31, 2009 and for the nine-months ended September 30, 2010"
05/11/2009 8-K/A Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits
Docs: "Consent of Independent Registered Public Accounting Firm",
"Audited consolidated financial statements of Indevus Pharmaceuticals, Inc. as of September 30, 2008 and for each of the three years ended September 30, 2008",
"Unaudited pro forma financial information for the year ended December 31, 2008"
05/01/2008 8-K/A Other Events
Docs: "Agreement between Endo Pharmaceuticals Holdings Inc. and D. E. Shaw Valence Portfolios, L.L.C. (on behalf of itself and its affiliates that are members of the 13D Group with respect to the Endo common stock)",
"ENDO PHARMACEUTICALS AND THE D.E. SHAW GROUP AGREE TO SETTLEMENT"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy